SEARCH

SEARCH BY CITATION

References

  • Albuisson J., Pecheux C., Carel J. C. et al. (2005) Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2). Hum. Mutat. 25, 9899.
  • Andrenacci D., Grimaldi M. R., Panetta V., Riano E., Rugarli E. I. and Graziani F. (2006) Functional dissection of the Drosophila Kallmann's syndrome protein DmKal-1. BMC Genet. 7, 47.
  • Ayari B. and Soussi-Yanicostas N. (2007) FGFR1 and anosmin-1 underlying genetically distinct forms of Kallmann syndrome are co-expressed and interact in olfactory bulbs. Dev. Genes. Evol. 217, 169175.
  • Bribián A., Barallobre M. J., Soussi-Yanicostas N. and de Castro F. (2006) Anosmin-1 modulates the FGF-2-dependent migration of oligodendrocyte precursors in the developing optic nerve. Mol. Cell. Neurosci. 33, 214.
  • Bribián A., Esteban P. F., Clemente D., Soussi-Yanicostas N., Thomas J. L., Zalc B. and de Castro F. (2008) A novel role for anosmin-1 in the adhesion and migration of oligodendrocyte precursors. Dev. Neurobiol. 68, 15031516.
  • Bülow H. E. and Hobert O. (2004) Differential sulfations and epimerization define heparan sulfate specificity in nervous system development. Neuron 41, 723736.
  • Bülow H. E., Berry K. L., Topper L. H., Peles E. and Hobert O. (2002) Heparan sulfate proteoglycan-dependent induction of axon branching and axon misrouting by the Kallmann syndrome gene kal-1. Proc. Natl Acad. Sci. USA 99, 63466351.
  • Cariboni A., Pimpinelli F., Colamarino S., Zaninetti R., Piccolella M., Rumio C., Piva F., Rugarli E. I. and Maggi R. (2004) The product of X-linked Kallmann's syndrome gene (KAL1) affects the migratory activity of gonadotropin-releasing hormone (GnRH)-producing neurons. Hum. Mol. Genet. 13, 27812791.
  • del Castillo I., Cohen-Salmon M., Blanchard S., Lutfalla G. and Petit C. (1992) Structure of the X-linked Kallmann syndrome gene and its homologous pseudogene on the Y chromosome. Nat. Genet. 2, 305310.
  • Chiaramello S., Dalmasso G., Bezin L., Marcel D., Jourdan F., Peretto P., Fasolo A. and De M. S. (2007) BDNF/ TrkB interaction regulates migration of SVZ precursor cells via PI3-K and MAP-K signalling pathways. Eur. J. Neurosci. 26, 17801790.
  • Church D. M., Goodstadt L., Hillier L. W. et al. (2009) Lineage-specific biology revealed by a finished genome assembly of the mouse. PLoS Biol. 7, e1000112.
  • Clemente D., Ortega M. C., Arenzana F. J. and de Castro F. (2011) FGF-2 and Anosmin-1 are selectively expressed in different types of multiple sclerosis lesions. J. Neurosci. 31, 1489914909.
  • Dodé C. and Hardelin J. P. (2004) Kallmann syndrome: fibroblast growth factor signaling insufficiency? J. Mol. Med. (Berl) 82, 725734.
  • Dodé C., Levilliers J., Dupont J. M. et al. (2003) Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat. Genet. 33, 463465.
  • Dodé C., Teixeira L., Levilliers J. et al. (2006) Kallmann syndrome: Mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet. 2, 16481652.
  • Endo Y., Ishiwata-Endo H. and Yamada K. M. (2012) Extracellular matrix protein anosmin promotes neural crest formation and regulates FGF, BMP, and WNT activities. Dev. Cell 23, 305316.
  • Franco B., Guioli S., Pragliola A. et al. (1991) A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 353, 529536.
  • García-González D., Clemente D., Coelho M., Esteban P. F., Soussi-Yanicostas N. and de Castro F. (2010) Dynamic roles of FGF-2 and Anosmin-1 in the migration of neuronal precursors from the subventricular zone during pre- and postnatal development. Exp. Neurol. 222, 285295.
  • Georgopoulos N. A., Pralong F. P., Seidman C. E., Seidman J. G., Crowley W. F., Jr and Vallejo M. (1997) Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadotropin-releasing hormone deficiency. J. Clin. Endocrinol. Metab. 82, 213217.
  • Georgopoulos N. A., Koika V., Galli-Tsinopoulou A. et al. (2007) Renal dysgenesis and KAL1 gene defects in patients with sporadic Kallmann syndrome. Fertil. Steril. 88, 13111317.
  • Gläser B., Myrtek D., Rumpler Y., Schiebel K., Hauwy M., Rappold G. A. and Schempp W. (1999) Transposition of SRY into the ancestral pseudoautosomal region creates a new pseudoautosomal boundary in a progenitor of simian primates. Hum. Mol. Genet. 8, 20712078.
  • González-Martínez D., Kim S. H., Hu Y., Guimond S., Schofield J., Winyard P., Vannelli G. B., Turnbull J. and Bouloux P. M. (2004) Anosmin-1 modulates fibroblast growth factor receptor 1 signaling in human gonadotropin-releasing hormone olfactory neuroblasts through a heparan sulfate-dependent mechanism. J. Neurosci. 24, 1038410392.
  • Govek E. E., Hatten M. E. and Van A. L. (2011) The role of Rho GTPase proteins in CNS neuronal migration. Dev. Neurobiol. 71, 528553.
  • Hardelin J. P., Levilliers J., Blanchard S., Carel J. C., Leutenegger M., Pinard-Bertelletto J. P., Bouloux P. and Petit C. (1993) Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome. Hum. Mol. Genet. 2, 373377.
  • Hu Y. and Bouloux P. M. (2011) X-linked GnRH deficiency: role of KAL-1 mutations in GnRH deficiency. Mol. Cell. Endocrinol. 346, 1320.
  • Hu Y., González-Martínez D., Kim S. H. and Bouloux P. M. (2004) Cross-talk of anosmin-1, the protein implicated in X-linked Kallmann's syndrome, with heparan sulphate and urokinase-type plasminogen activator. Biochem. J. 384, 495505.
  • Hu Y., Guimond S. E., Travers P., Cadman S., Hohenester E., Turnbull J. E., Kim S. H. and Bouloux P. M. (2009) Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1. J. Biol. Chem. 284, 2990529920.
  • Hudson M. L., Kinnunen T., Cinar H. N. and Chisholm A. D. (2006) C. elegans Kallmann syndrome protein KAL-1 interacts with syndecan and glypican to regulate neuronal cell migrations. Dev. Biol. 294, 352365.
  • Kallmann F. J., Schoenfeld W. A. and Barrera S. E. (1944) The genetic aspects of primary eunuchoidism. Am. J. Ment. Defic. XLVIII, 203236.
  • Kim S. H., Hu Y., Cadman S. and Bouloux P. (2008) Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome. J. Neuroendocrinol. 20, 141163.
  • Legouis R., Hardelin J. P., Levilliers J., Claverie J. M., Compain S., Wunderle V., Millasseau P., Le Paslier D., Cohen D. and Caterina D. (1991) The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 67, 423435.
  • Lutz B., Rugarli E. I., Eichele G. and Ballabio A. (1993) X-linked Kallmann syndrome. A neuronal targeting defect in the olfactory system? FEBS Lett. 325, 128134.
  • Maestre de San Juan A. (1856) Teratología: falta total de los nervios olfatorios con anosmia en un individuo en quien existía una atrofia congénita de los testículos y el miembro viril. El Siglo Médico, Madrid 3, 211.
  • Maya-Nuñez G., Zenteno J. C., Ulloa-Aguirre A., Kofman-Alfaro S. and Méndez J. P. (1998) A recurrent missense mutation in the KAL gene in patients with X-linked Kallmann's syndrome. J. Clin. Endocrinol. Metab. 83, 16501653.
  • Moors M., Cline J. E., Abel J. and Fritsche E. (2007) ERK-dependent and -independent pathways trigger human neural progenitor cell migration. Toxicol. Appl. Pharmacol. 221, 5767.
  • Murcia-Belmonte V., Esteban P. F., García-González D. and de Castro F. (2010) Biochemical dissection of Anosmin-1 interaction with FGFR1 and components of the extracellular matrix. J. Neurochem. 115, 12561265.
  • Oliveira L. M., Seminara S. B., Beranova M., Hayes F. J., Valkenburgh S. B., Schipani E., Costa E. M., Latronico A. C., Crowley W. F. Jr and Vallejo M. (2001) The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. J. Clin. Endocrinol. Metab. 86, 15321538.
  • Perry J., Palmer S., Gabriel A. and Ashworth A. (2001) A short pseudoautosomal region in laboratory mice. Genome Res. 11, 18261832.
  • Pitteloud N., Meysing A., Quinton R. et al. (2006) Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Mol. Cell. Endocrinol. 254–255, 6069.
  • Quinton R., Duke V. M., Robertson A. et al. (2001) Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization. Clin. Endocrinol. (Oxf) 55, 163174.
  • Robertson A., MacColl G. S., Nash J. A., Boehm M. K., Perkins S. J. and Bouloux P. M. (2001) Molecular modelling and experimental studies of mutation and cell-adhesion sites in the fibronectin type III and whey acidic protein domains of human anosmin-1. Biochem. J. 357, 647659.
  • Ross M. T., Grafham D. V., Coffey A. J. et al. (2005) The DNA sequence of the human X chromosome. Nature 434, 325337.
  • Rugarli E. I., Ghezzi C., Valsecchi V. and Ballabio A. (1996) The Kallmann syndrome gene product expressed in COS cells is cleaved on the cell surface to yield a diffusible component. Hum. Mol. Genet. 5, 11091115.
  • Sato N., Katsumata N., Kagami M. et al. (2004) Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients. J. Clin. Endocrinol. Metab. 89, 10791088.
  • Segarra J., Balenci L., Drenth T., Maina F. and Lamballe F. (2006) Combined signaling through ERK, PI3K/AKT, and RAC1/p38 is required for met-triggered cortical neuron migration. J. Biol. Chem. 281, 47714778.
  • Söderlund D., Canto P. and Méndez J. P. (2002) Identification of three novel mutations in the KAL1 gene in patients with Kallmann syndrome. J. Clin. Endocrinol. Metab. 87, 25892592.
  • Soussi-Yanicostas N., Hardelin J. P., Arroyo-Jiménez M. M., Ardouin O., Legouis R., Levilliers J., Traincard F., Betton J. M., Cabanie L. and Petit C. (1996) Initial characterization of anosmin-1, a putative extracellular matrix protein synthesized by definite neuronal cell populations in the central nervous system. J. Cell Sci. 109(Pt 7), 17491757.
  • Soussi-Yanicostas N., Faivre-Sarrailh C., Hardelin J. P., Levilliers J., Rougon G. and Petit C. (1998) Anosmin-1 underlying the X chromosome-linked Kallmann syndrome is an adhesion molecule that can modulate neurite growth in a cell-type specific manner. J. Cell Sci. 111(Pt 19), 29532965.
  • Tornberg J., Sykiotis G. P., Keefe K. et al. (2011) Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism. Proc. Natl Acad. Sci. USA 108, 1152411529.
  • Trarbach E. B., Baptista M. T., Garmes H. M. and Hackel C. (2005) Molecular analysis of KAL-1, GnRH-R, NELF and EBF2 genes in a series of Kallmann syndrome and normosmic hypogonadotropic hypogonadism patients. J. Endocrinol. 187, 361368.
  • Versiani B. R., Trarbach E., Koenigkam-Santos M., Dos Santos A. C., Elias L. L., Moreira A. C., Latronico A. C. and de Castro M. (2007) Clinical assessment and molecular analysis of GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism. Clin. Endocrinol. (Oxf) 66, 173179.
  • Yanicostas C., Ernest S., Dayraud C., Petit C. and Soussi-Yanicostas N. (2008) Essential requirement for zebrafish anosmin-1a in the migration of the posterior lateral line primordium. Dev. Biol. 320, 469479.
  • Zenaty D., Bretones P., Lambe C., Guemas I., David M., Leger J. and de Roux N. (2006) Paediatric phenotype of Kallmann syndrome due to mutations of fibroblast growth factor receptor 1 (FGFR1). Mol. Cell. Endocrinol. 254–255, 7883.